– USA, CA – DermTech, Inc. (NASDAQ: DMTK), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced the appointment of Nathalie Gerschtein, President of the Consumer Products Division of L’Oréal, to its board of directors.
“Nathalie has tremendous experience in building brands that consumers, clinicians, and the world recognize and trust,” said Board Chairman, Matt Posard. “Her unique and diverse perspectives will complement our efforts to make DermTech the trusted brand for genomic products that transform dermatologic care.”
About Nathalie Gerschtein Keraudy
Nathalie’s experience includes 20 years at L’Oréal—the world’s leading beauty company with a unique portfolio of 35 diverse brands, among which L’Oreal Paris, Skinceuticals, and Kiehl’s Since 1851—in roles of progressive leadership responsibility across Europe, Asia, and America. In Nathalie’s current role as president of the largest division in L’Oréal Group’s top subsidiary, Nathalie is responsible for accelerating growth, innovation, and sustainable practices across its mass-market portfolio of brands and product categories, from skincare and makeup to hair care and color. This extensive portfolio includes some of the most trusted and iconic brands including L’Oréal Paris, Maybelline New York, Garnier, and NYX Professional Makeup, in addition to Essie, Thayer’s Natural Remedies, Carol’s Daughter, and Softsheen-Carson.
Under Nathalie’s leadership, the consumer products division generates over $4.5 billion1 in U.S. retail sales annually. She leads a team of thousands of employees and remains committed to building a dynamic and inclusive culture.
“I’m honored to join the DermTech board of directors, not only because of the innovative and life-saving work I see the company doing but also because we share a common mission – to transform and democratize skincare for all,” said Ms. Gerschtein. “As part of my work with L’Oreal USA, I lead thousands of diverse and talented team members across the country who share my belief that high-quality and high-performing skincare can truly change lives for the better. I look forward to working with DermTech leadership to lead the genomic revolution in skin health.”
Nathalie graduated from HEC School of Management in Paris and received a Master of Business Administration with a focus in Corporate Strategy from London Business School. She also completed executive coursework at INSEAD’s senior executive leadership program.
About DermTech
DermTech is a leading genomics company in dermatology and is creating a new category of medicine, precision dermatology, enabled by our non-invasive skin genomics platform. DermTech’s mission is to transform dermatology with our non-invasive skin genomics platform, democratize access to high-quality dermatology care, and improve the lives of millions. DermTech provides genomic analysis of skin samples collected non-invasively using an adhesive patch rather than a scalpel. DermTech markets and develops products that facilitate the early detection of skin cancers and is developing products that assess inflammatory diseases and customized drug treatments.
For more information: https://dermtech.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
